23 November 2012

ALSFRS curves for NP001 response (twitpic.com)

Written by admin. Posted in News

Trackback from your site.

ALS-ETF partners with Denovo Biomarkers to leverage treatment access programs. genengnews.com/gen-news-highl… #ALS #BIOMARKERS

ALS Biomarkers partnership formed! See how treatment programs can benefit drug development bioportfolio.com/news/article…

@PeteFrates3 @SenWarren Great work, I hope you discussed near term treatment options through Expanded Access Programs.

1st Quarter Earnings from Cytokinetics, a company ALS patients should care about: seekingalpha.com/article/1386…

New FAQ release about expanded open-label treatment programs for ALS patients: alsetf.org/faq/